Acadia Pharmaceuticals Inc

Pharmaceutical company · San Diego, California, United States · Nasdaq: ACAD

Acadia Pharmaceuticals Inc is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker ACAD. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $86 million sold in a notice filed in 2013.

Profile compiled from public records. Is this your company? Request a correction or update

Acadia Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Stock listingNasdaq: ACAD
SEC industryPharmaceutical Preparations
SEC CIK1070494

What does Acadia Pharmaceuticals do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $1.6 million in total (2000 to 2014).

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $86.4 million sold (2013).

Frequently asked questions about Acadia Pharmaceuticals

Where is Acadia Pharmaceuticals headquartered?

Acadia Pharmaceuticals Inc is headquartered in San Diego, California, United States.

What does Acadia Pharmaceuticals do?

Acadia Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Acadia Pharmaceuticals a public company?

Yes. Acadia Pharmaceuticals Inc trades on Nasdaq under the ticker ACAD.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Acadia Pharmaceuticals: Headquarters, Locations & Company Profile (2026) | BioBridgeX